Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague-Dawley rats

Pharmacology Biochemistry and Behavior

Volumn 96, Issue 3, 2010, Pages 260-265

  Killinger, Bryan A ^a   Peet, Mary M ^a   Baker, Lisa E ^a  

^a WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

Drug discrimination; Kappa opioid receptors; Ketamine; LSD; Rats; Salvia divinorum; Salvinorin A

Indexed keywords

KAPPA OPIATE RECEPTOR; KETAMINE; LYSERGIDE; SALVINORIN A; AMINO ACID RECEPTOR BLOCKING AGENT; CLERODANE DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG DOSE INCREASE; HALLUCINATION; MALE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SPRAGUE DAWLEY RAT; TRAINING; ANIMAL; ANTAGONISTS AND INHIBITORS; DISCRIMINATION LEARNING; DOSE RESPONSE; DRUG EFFECTS; INSTRUMENTAL CONDITIONING; PERCEPTIVE DISCRIMINATION; STATISTICAL ANALYSIS;

ANIMALS; CONDITIONING, OPERANT; DATA INTERPRETATION, STATISTICAL; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DITERPENES, CLERODANE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; HALLUCINOGENS; KETAMINE; LYSERGIC ACID DIETHYLAMIDE; MALE; PSYCHOTROPIC DRUGS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; REINFORCEMENT SCHEDULE;

RATTUS; SALVIA DIVINORUM;

EID: 77954758120     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.05.014     Document Type: Article

References (37)

1. Baker L.E., Panos J.J., Killinger B.A., Peet M.M., Bell L.M., Haliw L.A., Walker S.L. Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats. Psychopharmacology 2009, 203:203-211.
2. Butelman E.R., Harris T.J., Kreek M.J. The plant-derived hallucinogen, salvinorin A, produces kappa opioid agonist-like discriminative effects in rhesus monkeys. Psychopharmacology 2004, 127:220-224.
3. Butelman E.R., Rus S., Prisinzano T.E., Kreek M.J. The discriminative effects of the k-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects. Psychopharmacology 2010, 10.1007/s00213-009-1771-5.
4. Colpaert F.C. Drug discrimination in neurobiology. Pharmacol Biochem Behav 1999, 64:337-345.
5. Drug Enforcement Administration. List of drugs and chemicals of concern. 2008; http://www.deadiversion.usdoj.gov/drugs_concern/salvia_d/salvia_d.htm Accessed 18 Jul 2009.
6. Extance K., Goudie A.J. Inter-animal olfactory cues in operant drug discrimination procedures in rats. Psychopharmacology 1981, 73:363-371.
7. Fantegrossi W.E., Murnane K.S., Reissig C.J. The behavioral pharmacology of hallucinogens. Biochemical Pharmacology 2008, 75:17-33.
8. Fiorella D., Rabin R.A., Winter J.C. The role of the 5-HT (2A) and 5-HT (2C) receptors in the stimulus effects of hallucinogenic drugs I: antagonist correlation analysis. Psychopharmacology 1995, 121:347-356.
9. Fontanilla D., Johannessen M., Hajipour A.R., Cozzi N.V., Jackson M.B., Ruoho A.E. The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 2009, 323(5916):934-937.
10. Gonzalez D., Riba J., Bouso J.C., Gomez-Jabaro G., Barbanoj M.J. Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug Alcohol Depend 2006, 85:157-162.
11. 2A receptor-mediated signaling pathways to affect behavior. Neuron 2007, 53:439-452.
12. Holtzman S.G., Locke K.W. Neural mechanisms of drug stimuli: experimental approaches. Psychopharmacology 1988, 4:138-153.
13. Holtzman S.G., Cook L., Steinfels G.F. Discriminative stimulus effects of spiradoline, a kappa-opioid agonist. Psychopharmacology. 1991, 105:447-452.
14. Krall C.M., Richards J.B., Rabin R.A., Winter J.C. Marked decrease of LSD-induced stimulus control in serotonin transporter knockout mice. Pharmacol Biochem Behav 2008, 88:349-357.
15. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M.B., Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine response. Archives of General Psychiatry 1994, 51:199-214.
16. Lambe E.K., Goldman-Rakic P.S., Aghajanian G.K. Serotonin induces EPSCs preferentially in layer V pyramidal neurons of the frontal cortex in the rat. Cerebral Cortex 2000, 10:974-980.
17. Lambe E.K., Aghajanian G.K. The role of Kv1.2-containing potassium channels in serotonin-induced glutamate release from thalamocortical terminals in rat frontal cortex. Journal of Neuroscience 2001, 21:9955-9963.
18. Lambe E.K., Aghajanian G.K. Prefrontal cortical network activity: opposite effects of psychedelic hallucinogens and D1/D5 dopamine receptor activation. Neuroscience 2007, 145:900-910.
19. Li J., Rice K.C., France C.P. Discriminative stimulus effects of 1-(2, 5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys. J Pharmacol Exp Ther 2008, 324:827-833.
20. Mori T., Nomura M., Yoshizawa K., Nagase H., Sawaguchi T., Narita M., Suzuki T. Generalization of NMDA-receptor antagonists to the discriminative stimulus effects of κ-opioid receptor agonists U-50,488H, but not TRK-820 in rats. J Pharmacol Sci 2006, 100:157-161.
21. O'Connor K.A., Roth B.L. Screening the receptorome for plant-based psychoactive compounds. Life Sciences 2005, 78:506-511.
22. Ortega A., Blount J.F., Manchand P.S. Salvinorin, a new transneoclerodane diterpene from Salvia divinorum (Labiatae). J Chem Soc 1982, 1:2505-2508.
23. Picker M.J., Doty P., Negus S.S., Mattox S.R., Dykstra L.A. Discriminative stimulus properties of U50488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists. J Pharmacol Exp Ther. 1990, 254:13-22.
24. Prisinzano T.E. Psychopharmacology of the hallucinogenic sage Salvia divinorum. Life Sciences 2005, 78:527-531.
25. Roth B.L., Baner K., Westkaemper R., Siebert D., Rice K.C., Steinberg S., Ernsberger P., Rothman R.B. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Nat Acad Sci 2002, 99:11934-11939.
26. Sadzot B., Baraban J.M., Glennon R.A., Lyon R.A., Leonhardt S., Jan C.R. Titeler M Psychopharmacology 1989, 98:495-499.
27. Shearman G.T., Herz A. Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate kappa-receptor agonists. Psychopharmacology 1982, 78(1):63-66.
28. Siebert D.J. Salvia divinorum and salvinorin A: new pharmacologic findings. J Ethnopharmacol 1994, 43:53-56.
29. Siebert DJ. Legal status of Salvia divinorum 2007; http://www.sagewisdom.org/legalstatus.html Accessed 10 Jul 2009.
30. Sorensen S.M., Kehne J.H., Fadayel G.M., Humphreys T.M., Ketteler H.J., Sullivan C.K., et al. Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies. J Pharmacol Exp Ther 1993, 266:684-691.
31. Vortherms T.A., Roth B.L. Salvinorin A from natural product to human therapeutics. Molecular Interventions 2006, 6:257-265.
32. Wasson R.G. A new Mexican psychotropic drug from the mint family. Botanical Museum Leaflets, Harvard University 1962, 20:77-84.
33. Wallach J.V. Endogenous hallucinogens as ligands of the trace amine receptors: a possible role in sensory perception. Medical Hypotheses 2009, 72:91-94.
34. Willmore-Fordham C.B., Krall D.M., McCurdy C.R., Kinder D.H. The hallucinogen derived from Salvia divinorum, salvinorin A, has k-opioid agonist discriminative stimulus effects in rats. Neuropharmacology 2007, 53:481-486.
35. Winter J.C., Doat M., Rabin R.A. Potentiation of DOM-induced stimulus control by non-competitive NMDA antagonists: a link between the glutamatergic and serotonergic hypotheses of schizophrenia. Life Sci 2000, 68:337-344.
36. Winter J.C., Eckler J.R., Rabin R.A. Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli. Psychopharmacology 2004, 172:233-240.
37. Winter J.C. Hallucinogens as discriminative stimuli in animals; LSD, phenethylamines, and tryptamines. Psychopharmacology 2009, 203:251-263.